Clinical Presentations

In this week's Homerun Slides, a look at empagliflozin and the effects of SGLT-2 inhibitors.

In this week's Homerun Slides, we start taking a look at the latest technology and medications to impact diabetes management.

In this week's Homerun Slides, we conclude our 12-part series with pharmacologic approaches to treating chronic kidney disease in type 2.

In this week's Homerun Slides, liraglutide's effects on and action in diabetes, and therapeutic ways to treat chronic kidney disease in people with type 2.

In this week's Homerun Slides, a focus on empagliflozin, another therapeutic approach in the treatment of CKD in this albuminuria presentation by Dr. Claude Lardinois.

In this week's Homerun Slides, testing albuminuria and potassium levels.

In this week's Homerun Slides, an explanation of some important diabetes trials such as EPPIC, SUN, BEACON, etc.

In this week's Homerun Slides, therapeutic approaches to chronic kidney disease beyond the renin–angiotensin system.

In this week's Homerun Slides, results of the HOPE trial and LIFE Study, and the main mediators that contribute to chronic kidney disease.

In this week's Homerun Slides, health conditions potentially indicated by albuminuria levels.